MANCHESTER, UNITED KINGDOM--(Marketwire - September 23, 2008) - Epistem plc (LSE: EHP), the UK biotechnology and contract research company, will present preclinical results from its recently completed plucked hair biomarker study at the American Association for Cancer Research (AACR) conference, “Molecular Diagnostics in Cancer Therapeutic Development: Fulfilling the Promise of Personalized Medicine” in Philadelphia on 23rd September 2008. This study was completed successfully on a candidate oncology drug from Ortho Biotech Oncology Research and Development (ORD), a Division of Janssen Pharmaceutica, N.V.
